Mark Sevecka
25 works · 521 citations · h-index 9
Top works
- State-based discovery: a multidimensional screen for small-molecule modulators of EGF signaling
- Dissecting protein function and signaling using protein microarrays
- Uncovering Quantitative Protein Interaction Networks for Mouse PDZ Domains Using Protein Microarrays
- Linear combinations of docking affinities explain quantitative differences in RTK signaling
- Receptor Tyrosine Kinases Fall into Distinct Classes Based on Their Inferred Signaling Networks
- Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic
- Lysate Microarrays Enable High-throughput, Quantitative Investigations of Cellular Signaling
- Predicting ligand-dependent tumors from multi-dimensional signaling features
- A Dual Array-Based Approach to Assess the Abundance and Posttranslational Modification State of Signaling Proteins
- Supplementary Table S1 from Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic
- Supplementary Tables S5, S6, S7, S8 from Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic
- Supplementary Tables S2, S3, S4 from Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic
- Supplementary Methods, Figures S1-S11, and Table Legends from Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic
- Data from Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic
- Data from Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic
- Abstract 1312: Predicting ligand-dependent tumors from multi-dimensional signaling features
- Supplementary Table S1 from Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic
- Supplementary Tables S5, S6, S7, S8 from Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic
- Supplementary Methods, Figures S1-S11, and Table Legends from Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic
- Supplementary Tables S2, S3, S4 from Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic